trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Kawano T et al. Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. 2004 Sep-Oct Anticancer Res. pmid:15517875
Fenic I et al. In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis. 2004 Sep-Oct J. Androl. pmid:15292114
Choi JH et al. Trichostatin A attenuates airway inflammation in mouse asthma model. 2005 Clin. Exp. Allergy pmid:15649272
Varshochi R et al. ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell line. 2005 J. Biol. Chem. pmid:15557281
Goeman F et al. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. 2005 Mol. Cell. Biol. pmid:15601862
Tai HH et al. Dynamic histone acetylation of late embryonic genes during seed germination. 2005 Plant Mol. Biol. pmid:16307366
Kook SH et al. Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. 2005 J. Biochem. Mol. Biol. pmid:16336792
Noh EJ et al. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells. 2005 Cancer Res. pmid:16357148
Wetzel M et al. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. 2005 J. Neurosurg. pmid:16383255
Hohl M and Thiel G Cell type-specific regulation of RE-1 silencing transcription factor (REST) target genes. 2005 Eur. J. Neurosci. pmid:16262660
Bernes S et al. Epigenetic and classical activation of Entamoeba histolytica heat shock protein 100 (EHsp100) expression. 2005 FEBS Lett. pmid:16263115
Gao S et al. CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. 2005 Thromb. Haemost. pmid:16268485
Li XX et al. Function of c-Fos-like and c-Jun-like proteins on trichostatin A-induced G2/M arrest in Physarum polycephalum. 2005 Acta Biochim. Biophys. Sin. (Shanghai) pmid:16270156
Francia G et al. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents. 2005 Mol. Cancer Ther. pmid:16227397
Chou SD et al. Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells. 2005 Int. Immunol. pmid:16210330
Bai Y et al. Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. 2005 J. Immunol. pmid:16210620
Chen G et al. [Enhancive effect of histone deacetylase inhibitor trichostatin a on transfection efficiency of adenovirus in ovarian carcinoma cell line A2780]. 2005 Ai Zheng pmid:16219132
Kasper LH et al. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. 2005 EMBO J. pmid:16237459
Columbaro M et al. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. 2005 Cell. Mol. Life Sci. pmid:16261260
Burlibaşa L and Gavrilă L Molecular and ultrastructural studies of the sperm chromatin from Triturus cristatus. 2005 Zygote pmid:16261764
Marengo E et al. Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. 2005 J Chromatogr A pmid:16301071
Juranek SA et al. snRNA and heterochromatin formation are involved in DNA excision during macronuclear development in stichotrichous ciliates. 2005 Eukaryotic Cell pmid:16278460
Chang CW et al. Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. 2005 Mol. Cell. Biol. pmid:16166624
Osada H et al. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. 2005 Mol. Carcinog. pmid:16163707
Rogier E et al. A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection. 2005 Kidney Int. pmid:16164666
Di-Poï N et al. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins. 2005 J. Biol. Chem. pmid:16166081
Spengler ML et al. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism. 2005 Cell. Signal. pmid:15494207
Valenzuela-Fernández A et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. 2005 Mol. Biol. Cell pmid:16148047
Davis FJ et al. Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15388503
Curtin BF et al. Histone acetylase inhibitor trichostatin A induces acetylcholinesterase expression and protects against organophosphate exposure. 2005 J. Cell. Biochem. pmid:16149071
Chen JS and Faller DV Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts. 2005 J. Cell. Physiol. pmid:15389542
Medugno L et al. The Krüppel-like zinc-finger protein ZNF224 represses aldolase A gene transcription by interacting with the KAP-1 co-repressor protein. 2005 Gene pmid:16150558
Frønsdal K and Saatcioglu F Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. 2005 Prostate pmid:15389787
Johnson J et al. Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid. 2005 Cell. Mol. Biol. (Noisy-le-grand) pmid:16171558
Karagiannis TC et al. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. 2005 Cancer Biol. Ther. pmid:16082178
Xiong Y et al. Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. 2005 Gynecol. Oncol. pmid:16024066
Xu CR et al. Histone acetylation affects expression of cellular patterning genes in the Arabidopsis root epidermis. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16176989
Wu P et al. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. 2005 Biochem. Biophys. Res. Commun. pmid:16051188
Yaneva M et al. Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. 2005 Nucleic Acids Res. pmid:16177181
Kang JE et al. Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1. 2005 Cell. Physiol. Biochem. pmid:16121030
Chen CS et al. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. 2005 J. Biol. Chem. pmid:16186112
Bradbury CA et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. 2005 Leukemia pmid:16121216
Cismasiu VB et al. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. 2005 Oncogene pmid:16091750
Fang MZ et al. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. 2005 Clin. Cancer Res. pmid:16203797
García-Morales P et al. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. 2005 Mol. Cancer Ther. pmid:16093438
Menegola E et al. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. 2005 Birth Defects Res. B Dev. Reprod. Toxicol. pmid:16193500
Nome RV et al. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. 2005 Mol. Cancer Ther. pmid:16093439
Kemp MG et al. The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells. 2005 Nucleic Acids Res. pmid:15653633
Huang H et al. MEIS C termini harbor transcriptional activation domains that respond to cell signaling. 2005 J. Biol. Chem. pmid:15654074
Danam RP et al. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. 2005 Mol. Cancer Ther. pmid:15657354
Li Y et al. Histone deacetylation is required for progression through mitosis in tobacco cells. 2005 Plant J. pmid:15659094
Gurvich N et al. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. 2005 FASEB J. pmid:15901671
Zhao Y et al. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. 2005 J. Exp. Biol. pmid:15695762
Hooven LA et al. Effects of suberoylanilide hydroxamic acid and trichostatin A on induction of cytochrome P450 enzymes and benzo[a]pyrene DNA adduct formation in human cells. 2005 Bioorg. Med. Chem. Lett. pmid:15713371
Chen B et al. Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:15713393
Duan H et al. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. 2005 Mol. Cell. Biol. pmid:15713621
Tong X et al. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors. 2005 J. Biol. Chem. pmid:15713675
Gan Y et al. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. 2005 J. Biol. Chem. pmid:15722551
Endo M et al. Novel gender-related regulation of CYP2C12 gene expression in rats. 2005 Mol. Endocrinol. pmid:15661834
Sengupta S et al. Tumor suppressor p53 represses transcription of RECQ4 helicase. 2005 Oncogene pmid:15674334
Busson M et al. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. 2005 Oncogene pmid:15674337
Wen J et al. Tal1/SCL binding to pericentromeric DNA represses transcription. 2005 J. Biol. Chem. pmid:15677454
Touma SE et al. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. 2005 Clin. Cancer Res. pmid:15867260
Fish JE et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. 2005 J. Biol. Chem. pmid:15870070
Dyson MH et al. MAP kinase-mediated phosphorylation of distinct pools of histone H3 at S10 or S28 via mitogen- and stress-activated kinase 1/2. 2005 J. Cell. Sci. pmid:15870105
Reid G et al. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. 2005 Oncogene pmid:15870696
Kim MS et al. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA). 2005 Exp. Cell Res. pmid:15878336
Rosenqvist N et al. Inhibition of chromatin condensation prevents transgene silencing in a neural progenitor cell line transplanted to the rat brain. 2005 Cell Transplant pmid:15881422
Gonçalves J et al. Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells. 2005 Clin. Chem. Lab. Med. pmid:15843208
Robbins AR et al. Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin. 2005 Cell Cycle pmid:15846093
Taghiyev AF et al. Trichostatin A (TSA) sensitizes the human prostatic cancer cell line DU145 to death receptor ligands treatment. 2005 Cancer Biol. Ther. pmid:15846101
Barki-Celli L et al. Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. 2005 Genes Chromosomes Cancer pmid:15846776
Law RD and Suttle JC Chromatin remodeling in plant cell culture: patterns of DNA methylation and histone H3 and H4 acetylation vary during growth of asynchronous potato cell suspensions. 2005 Plant Physiol. Biochem. pmid:15922608
Seo H et al. Rapid generation of specific antibodies by enhanced homologous recombination. 2005 Nat. Biotechnol. pmid:15924134
Song Y et al. [The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15854272
Xu ZM et al. [Analysis of the methylation in the promoter of LRP15 gene and its expression]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15854274
Mai A et al. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. 2005 J. Med. Chem. pmid:15857140
Ho WC et al. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. 2005 Cancer Res. pmid:15899819
Tran T et al. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. 2005 Cancer Res. pmid:15899836
Kaneda R et al. Genome-wide screening for target regions of histone deacetylases in cardiomyocytes. 2005 Circ. Res. pmid:16002748
Kusy S et al. Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. 2005 Biochim. Biophys. Acta pmid:16005989
Rho JH et al. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation. 2005 Int. J. Oncol. pmid:16010429
Choi YH Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. 2005 Int. J. Oncol. pmid:16010430
Taddei A et al. The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy? 2005 EMBO Rep. pmid:15940285
Gray SG et al. Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. 2005 J. Biol. Chem. pmid:15927959
Zhao W et al. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. 2005 J. Biochem. pmid:15809347
Subramanian C et al. Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:15778293
Lu ZP et al. Histone deacetylase inhibitor Trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription. 2005 Biochem. Biophys. Res. Commun. pmid:15781251
Nishigaki M et al. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays. 2005 Cancer Res. pmid:15781621
Bai J et al. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. 2005 Cancer Res. pmid:15781649
Rahmani M et al. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. 2005 Cancer Res. pmid:15781658
Frescas D et al. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. 2005 J. Biol. Chem. pmid:15788402
Kang J et al. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. 2005 Biochem. Pharmacol. pmid:15794941
Narayanan R et al. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. 2005 Mol. Cell. Biol. pmid:15798179
Koh SH et al. Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death. 2005 Biochem. Biophys. Res. Commun. pmid:15752760
Mori T et al. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. 2005 Cancer Res. pmid:15753377
Dowling M et al. Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. 2005 Cancer Biol. Ther. pmid:15753652
Dote H et al. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. 2005 Br. J. Cancer pmid:15770214
Laberge RM and Boissonneault G On the nature and origin of DNA strand breaks in elongating spermatids. 2005 Biol. Reprod. pmid:15772260
McKenzie GJ et al. Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. 2005 J. Neurochem. pmid:15773917